新聞Bragar Eagel & Squire PC filed suit against Sppirx on Sep 24th '25.SPECTRUM FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds investors of the Class action lawsuit filed against Spectrum Pharmaceuticals, Inc. and Encourages Investors to contact the firm before September 24th.
新聞Srivastava left Sppirx as Global Compliance Officer on Dec 22nd '23.Mr. Srivastava joins BPGbio from Spectrum Pharmaceuticals, a publicly traded biopharmaceutical company, where he held several leadership roles for over five years, including most recently as Global Compliance Officer.
新聞Sppirx has issues with possible breaches of fiduciary duty and other violations of law.Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Spectrum Pharmaceuticals, Inc. ("Spectrum Pharmaceuticals" or the "Company") SPPI, in connection with its acquisition by Assertio Holdings, Inc.
